CompletedNot Applicable

Supplements SMOF in TPN for Liver Transplantation Recipients

Taiwan54 participantsStarted 2012-01-01

Plain-language summary

Liver transplantation (LT) is one of the widely recognised and leading treatments for end-stage liver disease. Nutrition impacts its success. Total parenteral nutrition (TPN) is usually prescribed for patients recommended prolonged fasting after LT. The supplement of SMOFlipid (soybean oil, MCT oil, olive oil, and fish oil) is easily metabolised to produce energy, and it possesses anti-inflammatory effects; however, SMOFlipid emulsion use raises concerns regarding coagulopathy after LT. This study investigated the postoperative correlation between SMOFlipid and coagulation in LT.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Renal dysfunction (eGFR \< 60 mL/min/1.73 m2)
✕. Patients with well-tolerated oral intake and those in whom the TPN supplement was discontinued within 10 days were excluded from this study.

What they're measuring

Patient demographics and clinical characteristics of SMOFlipid and non-SMOFlipid groups

Timeframe: 30 days

Coagulopathy profile and nutrition profile in SMOF group and non-SMOFlipid groups

Timeframe: 30 days

Trial details

NCT IDNCT04572373

SponsorChang Gung Memorial Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2015-06-30

View on ClinicalTrials.gov More Liver Transplantation trials